AstraZeneca Under Soriot: Progress Report

Last week, AstraZeneca's CEO Pascal Soriot was rumored to be preparing for a move to run Teva Pharmaceutical Industries. This week, he's rumored to be staying put. Scrip takes a look at the key moments in his tenure at the UK big pharma, and the progress on targets.

Report card
How is Soriot doing in Year 5 at AstraZeneca?

More from Business

More from Scrip